(JREG) JPMorgan s (Ireland) ICAV - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: IE00BF4G6Y48 • Global Large-Cap Blend Equity
JREG: Global, Large-Cap, Equity, ETF, Blend
The JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (acc) CHF (SW:JREG) is designed to deliver long-term returns exceeding its benchmark through active global equity investments. This UCITS-compliant ETF trades in Swiss Francs and leverages J.P. Morgan Asset Managements expertise to enhance returns. It primarily invests in global companies, using a quantitative approach to identify undervalued stocks with strong fundamentals. The fund is benchmarked against the Morningstar Global TME NR USD Index and is structured to appeal to investors seeking global large-cap exposure with a blend of growth and value.
From a technical standpoint, the ETF is currently trading below its key moving averages, with the last price of 40.63 falling under the 20-day (47.23), 50-day (49.53), and 200-day (50.14) SMAs. This indicates a bearish trend in the short to medium term. The Average True Range (ATR) of 1.11 suggests moderate volatility, while the average 20-day volume of 2,958 indicates limited liquidity compared to larger ETFs. The funds assets under management (AUM) of $4.648 billion highlight its scale and investor confidence in the strategy.
Over the next three months, the ETF is expected to face headwinds due to its current position below key SMAs, signaling potential continued weakness. The relatively low ATR suggests price movements may remain constrained, with limited upside or downside surprises. However, the funds significant AUM and institutional backing provide stability, making it less vulnerable to sharp declines. Investors should monitor the ETFs ability to reclaim its 20-day and 50-day SMAs as a potential signal for trend reversal.
Additional Sources for JREG ETF
JREG ETF Overview
Market Cap in USD | 4,648m |
Category | Global Large-Cap Blend Equity |
IPO / Inception | 2018-10-10 |
JREG ETF Ratings
Growth Rating | 62.6 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -18.3 |
Analysts | - |
Fair Price Momentum | 36.86 USD |
Fair Price DCF | - |
JREG Dividends
No Dividends PaidJREG Growth Ratios
Growth Correlation 3m | -74.4% |
Growth Correlation 12m | 47% |
Growth Correlation 5y | 81.4% |
CAGR 5y | 10.70% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 0.90 |
Alpha | -17.33 |
Beta | 0.595 |
Volatility | 20.50% |
Current Volume | 0.1k |
Average Volume 20d | 2.6k |
As of May 12, 2025, the stock is trading at USD 41.82 with a total of 141 shares traded.
Over the past week, the price has changed by -17.16%, over one month by -9.98%, over three months by -19.78% and over the past year by -10.52%.
Yes. Based on ValueRay Analyses, JPMorgan s (Ireland) ICAV (SW:JREG) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.64 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JREG as of May 2025 is 36.86. This means that JREG is currently overvalued and has a potential downside of -11.86%.
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
According to ValueRays Forecast Model, JREG JPMorgan s (Ireland) ICAV will be worth about 40.7 in May 2026. The stock is currently trading at 41.82. This means that the stock has a potential downside of -2.63%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 40.7 | -2.6% |